In this approach, we propose the use of MSCs expressing GM-CSF, a key cytokine to stimulate the antitumoural immune response [57], potentiated by the combination with Dox, which induces DAMPs liberation leading to enhance the activation of the immune system within the tumour microenvironment. The gene discussed is CSF2; the disease is neoplasm.